المؤلفون: André Pechinot, F. Huet, M. Hadjiat-Savioz, Catherine Neuwirth, Jean-Marie Duez, N. Sixt, Eliane Siebor, K. Astruc, J. Bador

المساهمون: Centre de génétique - Centre de référence des maladies rares, anomalies du développement et syndromes malformatifs (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Laboratoire de Bactériologie (CHU Dijon), Laboratoire de bactériologie (CHU Dijon), Plateau technique de Biologie [CHU de Dijon], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)

المصدر: Journal of chemotherapy (Florence, Italy)
Journal of chemotherapy (Florence, Italy), 2010, 22 (2), pp.139-41

مصطلحات موضوعية: MESH: Piperacillin, medicine.drug_class, Antibiotics, Microbial Sensitivity Tests, In Vitro Techniques, MESH: Tobramycin, MESH: Drug Synergism, MESH: Dose-Response Relationship, Drug, Microbiology, MESH: Anti-Bacterial Agents, Drug Resistance, Bacterial, MESH: Drug Resistance, Bacterial, medicine, Tobramycin, Pharmacology (medical), ComputingMilieux_MISCELLANEOUS, Antibacterial agent, Piperacillin, Pharmacology, MESH: Microbial Sensitivity Tests, Dose-Response Relationship, Drug, biology, Aminoglycoside, Drug Synergism, MESH: Aminoglycosides, Biological activity, Achromobacter xylosoxidans, biology.organism_classification, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, Anti-Bacterial Agents, Aminoglycosides, Infectious Diseases, Oncology, MESH: Achromobacter denitrificans, Achromobacter denitrificans, Bacteria, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c66dbf24b7787f58e6804fc3e073cb1
https://doi.org/10.1179/joc.2010.22.2.139